Elon Musk Makes Big Announcement About New Technology
The neurotechnology company co-founded by Elon Musk, Neuralink, is set for what could be world-changing human trials soon.
Musk recently revealed that Neuralink will begin human trials for the company's first implants for vision within the next year.
"In the next six to 12 months, we'll be doing our first implants for vision, where even if somebody is completely blind, we can write directly to the visual cortex," Musk said to Y Combinator on Thursday.
Neuralink has already tested the implant on a monkey, and Musk says that the animal has had it for three years. He adds that the vision offered from the implant would be in low resolution at first, but will improve over time.
"Long term, it'll be very high resolution and you'll be able to see multi-spectral wavelengths," Musk revealed.
Musk said back in April that the vision of the people who use the implant "will exceed the best human eyes."
The "Blindsight" implant will enable its users to see ultraviolet rays, infrared and radar "like a superpower situation," the Tesla CEO added.
Neuralink's brain-computer interface (BCI) has already seen some success. The BCI was inserted into the brain of Noland Arbaugh, a paralyzed man who is now able to control computers with his thoughts thanks to the technology.Elon Musk Makes Big Announcement About New Technology first appeared on Men's Journal on Jun 21, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes
Common obesity drug reduced the risk of disease progression by 54% CHICAGO, June 21, 2025 /PRNewswire/ -- Today, a new analysis demonstrates the vascular benefits of semaglutide in patients with peripheral artery disease (PAD) and type 2 diabetes, including improvement in symptoms, quality of life, and disease progression in patients. An analysis of the STRIDE trial was presented as a late-breaking symposium at the 85th Scientific Sessions of the American Diabetes Association® (ADA) in Chicago and simultaneously published in Diabetes Care®. PAD is a serious condition impacting 230 million individuals globally and up to 30% of people with diabetes. PAD narrows arteries and reduces blood flow to the legs, causing marked disability, affecting quality of life, and putting people at increased risk of severe complications including amputations and death. Treatment options are currently limited, and little advancements in PAD treatment have occurred for more than 25 years. The STRIDE trial is a phase 3, multinational, double-blind, randomized clinical trial conducted at 112 outpatient clinical trial sites in 20 countries in North America, Asia, and Europe. 792 patients aged 18 years and older with type 2 diabetes and PAD with intermittent claudication (a symptom of PAD that causes muscle pain or cramping in the legs during physical activity) and reduced ankle-brachial or toe-brachial index (indicators of restricted blood flow to the legs), were randomly assigned to receive either semaglutide (n=396) or placebo (n=396) over a 52-week period to assess the impact on walking capacity, symptoms, and quality of life. The median age was 68 years, and 195 (25%) participants were female and 597 (75%) were male. The sub-analysis builds on results previously published in The Lancet, demonstrating that semaglutide significantly improved walking outcomes in people with PAD and diabetes, enhanced quality of life, and reduced the risk of disease progression by 54%. At week 52, the estimated median ratio to baseline in maximum walking distance was 1.21 in the semaglutide group compared to 1.08 in the placebo group. Semaglutide was well tolerated, with no treatment-related deaths and a low rate of serious adverse events (1%), consistent with its known safety profile. The analyses from STRIDE presented new and critical information on the benefits of semaglutide, which were observed independent of baseline levels of A1C, duration of diabetes, or intensity of diabetes. Furthermore, the benefits were seen across all BMI categories and regardless of the treatment with SGLT2 inhibitors. "These findings indicate that clinicians can now recognize semaglutide as a vascular protective medication, with benefits that extend beyond lowering weight or A1C," said Professor Subodh Verma, MD, PhD, FRCSC, FAHA, FCAHS, cardiovascular surgeon, University of Toronto, Toronto, Canada, and senior author of the STRIDE trial. "The totality of data now suggest that in people with diabetes, semaglutide favorably affects the pipes [atherosclerosis], pump [heart failure], filter [kidney outcomes]. And, in patients with PAD, these new data provide robust evidence that semaglutide is a therapy to improve their function, quality of life, and progression of disease."The study authors indicate that further research is warranted to understand whether these benefits extend to individuals with PAD who do not have diabetes. Research presentation details:Dr. Verma will present the findings at the following symposium: Symposium: Diabetes and Peripheral Artery Disease—Evolving Role of GLP-1 RA and New Insights from the STRIDE Trial Presented on Saturday, June 21 at 1:30 p.m. CT About the ADA's Scientific SessionsThe ADA's 85th Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be held in Chicago, IL, on June 20–23. Thousands of leading physicians, scientists, and health care professionals from around the world are expected to convene both in person and virtually to unveil cutting-edge research, treatment recommendations, and advances toward a cure for diabetes. Attendees will receive exclusive access to thousands of original research presentations and take part in provocative and engaging exchanges with leading diabetes experts. Join the Scientific Sessions conversation on social media using #ADASciSessions. About the American Diabetes AssociationThe American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure—and we're not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we're fighting for them all. To learn more or to get involved, visit us at or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn). Media Contact: Mimi Carmody, MCarmody@ View original content to download multimedia: SOURCE American Diabetes Association Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
Republican plans to cap student borrowing could shatter an everyday profession
A series of changes to long-running federal student loan programs tucked into the Republican tax plan has doctors panicked and struggling to find GOP allies. The Senate education committee's portion of President Donald Trump's 'big, beautiful' billincludes a new cap on how much people can borrow for medical school and other professional programs that is well below the sticker price most students are facing. Lawmakers are also proposing to nix a class of federal loans graduate students use to cover housing and other non-tuition expenses. For low-income and first-generation college students with aspirations of becoming physicians, these plans, if enacted, could squash their dreams, according to medical college leaders. As the full Senate irons out the bill and Trump rattles school finances with funding freezes, doctors' groups are asking Congress to preserve the more generous loan options or risk a sharp drop in who's studying medicine — a profession that's already facing a shortage. While part of the stress on poorer students comes from the ever-increasing cost of higher education, the bill would likely push more of them toward private loans that require a co-signer, which are out of reach for many, and come with steeper interest rates. 'A lot of our medical schools, mine included, have a lot of first-generation college students. When they come into medical education, more times than not, they don't have co-signers,' said John L. Hummer, president of Burrell College of Osteopathic Medicine, a school with campuses in New Mexico and Florida for which 81 percent of students depend on the federal Grad PLUS program Republicans are looking to eliminate. The Senate education tax bill establishes a $200,000 ceiling on federal student loans for professional degrees, like medicine. But the median cost of attending four years of medical school for the class of 2025 is $286,454 for public institutions and $390,848 for private schools, according to the Association of American Medical Colleges. It's a range that exceeds the costs many doctors now serving in Congress paid when they earned their degrees. Many did not respond to inquiries from POLITICO about how the One Big Beautiful Bill Act would affect medical school enrollment — and those that did were not sympathetic about student debt. 'You're looking at a person, a first-generation college student, who went to medical school, and didn't borrow money,' Sen. Roger Marshall (R-Kan.), who sits on the Senate HELP Committee, said. 'I worked my tail off. Anyone who is paying more than $100,000 to go to school is making a huge mistake.' Marshall graduated from the University of Kansas School of Medicine in 1987, when the average in-state tuition for a public medical school nationally was around $4,696. That sum in today's dollars is about $13,300 — far less than what the Kansas program costs in 2025. Members of the medical community believe limits on federal loans or steering students to borrow from private lenders will exacerbate a long-running national physician shortage the Association of American Medical Colleges projects could be as high as 86,000 doctors by 2036. David Bergman, senior vice president of government relations and health affairs at the American Association of Colleges of Osteopathic Medicine, said students at medical schools his group represents have said it's been difficult to access private loans. Some lenders, like PNC Bank, hold student debt for which about 90 percent of private loans have a co-signer, while others had interest rates as high as 16 percent — nearly twice that of a Grad PLUS loan. 'The consequence of all this, of course, is that it's the low-income students who are going to suffer the most,' Bergman said. 'They may not have great credit, so then they may not be able to get the loans. Or they may get higher rate loans that put them further in debt.' One former Trump administration official shares this concern. 'I do worry about the assumption that the private sector is going to step in,' said Diane Jones, a former Education Department official from Trump's first term. 'Maybe they would, but I'm not sure they would step in to make loans available to low-income students.' Even some people in the lending business are skeptical the industry's bigger players will change their rules around co-signers. 'It just takes a lot more energy because it's riskier. Period. Banks aren't in the business of doing riskier products,' said Ken Ruggiero, co-founder and CEO of Ascent, a private loan company that will lend to applicants without a co-signer. 'They are in the business of talking to a person who has a very good income and credit score and letting the student sign the agreement.' The House version of the bill would also shut down Grad PLUS and put a cap on lending to graduate students for professional programs, putting pressure on the Senate to change course. But HELP Committee Chair Sen. Bill Cassidy (R-La.) said there needs to be more accountability for the high tuition prices writ large that aren't exclusive to medical schools. 'There should be some ratio between earning potential and what it costs,' Cassidy said. 'I met with neurosurgeons and cosmetologists and they had the same discussion about the cost of education.' Jason Goldman, president of the American College of Physicians, which represents internal medicine doctors, related specialists and medical students, is skeptical that capping loan amounts would force medical schools to immediately lower tuition. Over the span of 21 years, medical school tuition has gone up 81 percent, outpacing inflation, according to AAMC. 'The reality is it's very expensive to train a physician — the amount of hours that go into lectures, labs, professors and housing and everything it takes to graduate is expensive,' Goldman said. He fears that some students may be dissuaded from becoming primary care doctors, a specialty where shortages are profound, especially in rural areas. Some in Congress have pushed Education Secretary Linda McMahon to address proposed limits to federal lending for student borrowers pursuing health care-related degrees. During a House Appropriations Committee hearing in May, Rep. Lois Frankel (D-Fla.) asked McMahon to take a look at aid programs that help students complete their degrees. 'We do know we have a shortage of nurses and doctors,' McMahon said. 'I think there are a lot of programs we can look at to train nurse technicians to get them into the marketplace faster.' Other Congress members have proposed student loan changes outside of the One Big Beautiful Bill Act to address health care shortages. Sens. Roger Wicker (R-Miss.) and Jackie Rosen (D-Nev.) introduced legislation in April that would create a student loan repayment program for specialists within medical professions who practice in rural areas. They also introduced the Specialty Physicians Advancing Rural Care Act in previous legislative sessions citing a dearth of providers in rural communities. 'The entire nation is dealing with a physician shortage, and rural communities in Mississippi have been particularly affected,' Wicker said in a statement. 'Congress can help provide a solution.' Jones, the official from Trump's first term, also worries that some students may have to forgo medical school because they won't be able to secure financial assistance. She attended medical school in the 1980s when the loan program she was using was suspended, ultimately leading her to drop out because she could no longer afford the program. 'I didn't have a parent who could co-sign for a private loan, and I didn't have access to any other resources,' she said. 'I personally lost the opportunity to pursue the career that I wanted, that I had earned the right to pursue.'
Yahoo
24 minutes ago
- Yahoo
Botanical Gardens celebrates $31M renovation project
BUFFALO, N.Y. (WIVB) — Local and state officials are celebrating the groundbreaking of a $31 million renovation and expansion project for the Buffalo and Erie County Botanical Gardens. 'Much like a thriving plant that has become too large for its pot, the Botanical Gardens has outgrown its current spaces and we are ready to grow beyond the glass,' said Erin Grajek, president & CEO of the Botanical Gardens. The Botanical Gardens has had gardens blossoming since 1900. It welcomes more than 100,000 visitors a year and now is seeing a transformation. The project includes 90,000 square feet of renovation for planting new gardens, 14,000 square feet of renovations, and more than 16,000 square feet of new construction. The transformation will include new features, including a new welcome center, an expanded gift shop, a Garden Market Cafe, two new classrooms in a Learning Lab, new event spaces, a Horticulture Center, and sustainability and accessibility initiatives. 'To have a community that you can be proud of, you've got to go big and that's what this additional project is. It's going big to build on the legacy of the past to ensure this facility, the main gardens building, of course, are here for more than another 125 years, but that we're able to take advantage of what this brings to our greater community,' said Erie County Executive Mark Poloncarz. New York State is investing $12 million into the project, and Erie County is investing $7 million into the project that is anticipated to be complete in late 2026 or early 2027. 'A $31 million investment signals that this community matters, and sometimes people who live here all their lives, they overlook how extraordinary this community is,' said Gov. Kathy Hochul. The Botanical Gardens says 94% of the funding has been raised and there's $2 million to go to reach $31 million. They've started a public capital campaign called 'Growing Beyond the Glass' to raise the remaining funds needed. To find out more information about the project or to donate to the campaign, visit the Buffalo and Erie County Botanical Gardens here. Hope Winter is a reporter and multimedia journalist who has been part of the News 4 team since 2021. See more of her work here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
